FDA should establish a public database of device labels, experts say
Regulatory NewsJoanne S. Eglovitch
510(k)Advertising, Promotion and LabelingDe novoMedical DevicesPremarket approval (PMA)Regulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)